Malta - English - Medicines Authority

auxilto healthcare s.r.o. bucharova 2657/12, stodulky 158 00 praha 5 , czech republic - tablet - vildagliptin 50 mg - drugs used in diabetes

Ireland - English - HPRA (Health Products Regulatory Authority)

novo nordisk a/s - glucagon - pdr+solv for soln for inj - 1 milligram

India - English - Central Drugs Standard Control Organization

novo nordisk - glucagon - 1mg/ml - 1 u.

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - sitagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - for patients with type 2 diabetes mellitus:janumet is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin.janumet is indicated in combination with a sulphonylurea (i.e., triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.janumet is indicated as triple combination therapy with a ppar  agonist (i.e., a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a ppar  agonist.janumet is also indicated as add on to insulin (i.e., triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dosage of insulin and metformin alone do not provide adequate glycaemic control.

European Union - English - EMA (European Medicines Agency)

sanofi winthrop industrie - lixisenatide - diabetes mellitus, type 2 - drugs used in diabetes, glucagon-like peptide-1 (glp-1) analogues - lyxumia is indicated for the treatment of adults with type 2 diabetes mellitus to achieve glycaemic control in combination with oral glucose lowering medicinal products and/or basal insulin when these, together with diet and exercise, do not provide adequate glycaemic control.,

European Union - English - EMA (European Medicines Agency)

merck sharp & dohme b.v. - sitagliptin, metformin hydrochloride - diabetes mellitus, type 2 - drugs used in diabetes - for patients with type-2 diabetes mellitus:ristfor is indicated as an adjunct to diet and exercise to improve glycaemic control in patients inadequately controlled on their maximal tolerated dose of metformin alone or those already being treated with the combination of sitagliptin and metformin.ristfor is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a sulphonylurea.ristfor is indicated as triple combination therapy with a peroxisome proliferator-activated-receptor-gamma (pparγ) agonist (i.e. a thiazolidinedione) as an adjunct to diet and exercise in patients inadequately controlled on their maximal tolerated dose of metformin and a pparγ agonist.ristfor is also indicated as add-on to insulin (i.e. triple combination therapy) as an adjunct to diet and exercise to improve glycaemic control in patients when stable dose of insulin and metformin alone do not provide adequate glycaemic control.

European Union - English - EMA (European Medicines Agency)

novo nordisk a/s - liraglutide - obesity; overweight - drugs used in diabetes - saxenda is indicated as an adjunct to a reduced-calorie diet and increased physical activity for weight management in adult patients with an initial body mass index (bmi) of• ≥ 30 kg/m² (obese), or• ≥ 27 kg/m² to < 30 kg/m² (overweight) in the presence of at least one weight-related comorbidity such as dysglycaemia (pre-diabetes or type 2 diabetes mellitus), hypertension, dyslipidaemia or obstructive sleep apnoea.treatment with saxenda should be discontinued after 12 weeks on the 3.0 mg/day dose if patients have not lost at least 5% of their initial body weight.

United States - English - NLM (National Library of Medicine)

20lighter health & wellness, llc - 20l - a peptides, 20l-b peptides, a-ketoglutaricum acidum, anacardium orientale a-lipoicum acidum argentum nitricum asclepias vincetoxicum atp avena sativa belladonna bile duct suis brain suis calcarea carbonica carduus marianus ceanothus americanus chelidonium majus cholesterinum cinchona officinalis colon suis conduranfo cynara scolymus duodenum suis dysentery bacillus echinacea equol esophagus suis eye mucosa suis formicum acidum gallblader suis gambogia gelsemium sempervirens glucagon glyoxal graphites - for temporary relief of symptms of excess body fat and the inability to metabolize body fat. for temporary relief of symptms of excess body fat and the inability to metabolize body fat. use as prescribed.

United States - English - NLM (National Library of Medicine)

integra health international, s.a. de c.v. - 20l - a peptides, 20l-b peptides, a-ketoglutaricum acidum, anacardium orientale a-lipoicum acidum argentum nitricum asclepias vincetoxicum atp avena sativa belladonna bile duct suis brain suis calcarea carbonica carduus marianus ceanothus americanus chelidonium majus cholesterinum cinchona officinalis colon suis conduranfo cynara scolymus duodenum suis dysentery bacillus echinacea equol esophagus suis eye mucosa suis formicum acidum gallblader suis gambogia gelsemium sempervirens glucagon glyoxal graphites - for temporary relief of symptms of excess body fat and the inability to metabolize body fat. for temporary relief of symptms of excess body fat and the inability to metabolize body fat. use as prescribed.

United States - English - NLM (National Library of Medicine)

seriously slim - active ingredients: asclepias vincetoxicum 6x, 12x, 30x, echinacea 6x, 12x, 30x, hypothalamus (suis) 6x, 12x, 30x, brain (suis) 8x, hepar suis 8x, methylcobalamin 8x, pancreas suis 8x, renal (suis) 8x, stomach (suis) 8x, aacg-a 8x, 12x, 30x, 60x, 200x, aacg-b 8x, 12x, 30x, 60x, 200x, calcarea carbonica 12x, 30x, 60x, gambogia 12x, 30x. 60x, gelsemium sempervirens 12x, 30x, 60x, graphites 12x, 30x, 60x, nux vomica 12x, 30x, 60x, phytolacca decandra 12x, 30x, 60x, 7-keto dhea 30x, atp 30x, glucagon 30x, insul - indications: for temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue and detoxification stress. indications: for temporary relief of symptoms related to increased appetite, regulation of fat metabolism, headache, fatigue and detoxification stress.